BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, van Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev 2021;301:122-44. [PMID: 33709421 DOI: 10.1111/imr.12965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mao L, Xu L, Wang X, Xing Y, Wang J, Zhang Y, Yuan W, Du J, Shi Z, Ma J, Zhang J, Zhang X, Wang X. Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster. Tuberculosis 2022. [DOI: 10.1016/j.tube.2022.102186] [Reference Citation Analysis]
2 Kumar NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, Nancy A, Jeyadeepa B, Selvaraj N, Ashokan D, Renji RM, Venkataramani V, Tripathy S, Babu S. BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals. Int J Infect Dis 2021;110:98-104. [PMID: 34302964 DOI: 10.1016/j.ijid.2021.07.041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Nanomaterials (Basel) 2021;11:2060. [PMID: 34443891 DOI: 10.3390/nano11082060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, van Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev 2021;301:122-44. [PMID: 33709421 DOI: 10.1111/imr.12965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Netea MG, Domínguez-andrés J, van de Veerdonk FL, van Crevel R, Pulendran B, van der Meer JW. Natural resistance against infections: focus on COVID-19. Trends in Immunology 2021. [DOI: 10.1016/j.it.2021.12.001] [Reference Citation Analysis]
6 Gnimavo R, Besnard A, Degnonvi H, Pipoli Da Fonseca J, Kempf M, Johnson CR, Boccarossa A, Brou YT, Marsollier L, Marion E. Molecular and epidemiological characterization of recurrent Mycobacterium ulcerans infections in Benin. PLoS Negl Trop Dis 2021;15:e0010053. [PMID: 34962930 DOI: 10.1371/journal.pntd.0010053] [Reference Citation Analysis]
7 Schorey JS, Cheng Y, McManus WR. Bacteria- and host-derived extracellular vesicles - two sides of the same coin? J Cell Sci 2021;134:jcs256628. [PMID: 34081134 DOI: 10.1242/jcs.256628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Setiabudiawan TP, Reurink RK, Hill PC, Netea MG, van Crevel R, Koeken VA. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective. Med 2022;3:6-24. [DOI: 10.1016/j.medj.2021.11.006] [Reference Citation Analysis]
9 Luo XB, Li LT, Xi JC, Liu HT, Liu Z, Yu L, Tang PF. Negative pressure promotes macrophage M1 polarization after Mycobacterium tuberculosis infection via the lncRNA XIST/microRNA-125b-5p/A20/NF-κB axis. Ann N Y Acad Sci 2022. [PMID: 35579934 DOI: 10.1111/nyas.14781] [Reference Citation Analysis]
10 Sivakumaran D, Jenum S, Ritz C, Vaz M, Doherty TM, Grewal HMS. Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis? Front Immunol 2022;13:801616. [DOI: 10.3389/fimmu.2022.801616] [Reference Citation Analysis]